Practice Management News

In this guest commentary, Amrita Sethi, MD, and Uzma Siddiqui, MD, leaders of Women in Endoscopy (WIE), address the recent Twitter-storm over the low number of women matched in advanced endoscopy fellowships for the upcoming year. Tyler Berzin, MD, FASGE, pointed out that only nine of the 70 matched fellowships would be occupied by women in 2019, for a rate of just 12.9%.

Patients who were black, women or who were at risk for opioid-related harm were more likely to be prescribed chronic opioids, according to findings recently published in the Annals of Family Medicine.

Two lawmakers introduced legislation today that they said would lower the price of prescription drugs for Americans, according to a press release.

The U.S. Preventive Services Task Force recently gave an ‘A’ level recommendation to screening women for hepatitis B during their first prenatal visit, according to a report recently published in JAMA.

The lawsuit involving the manufacturer of Suboxone film that was settled earlier this month for a record-breaking $1.4 billion could change the generic drug approval process and highlighted treatment barriers for patients with opioid use disorder, legal experts told Healio Primary Care.

The American Association for the Study of Liver Diseases Foundation has granted $3.42 million in research and career development awards to 29 researchers and clinicians to conduct liver disease research and undergo advanced hepatology training.

Proper disposal of unused prescription medication remains a major public health priority for the FDA, particularly for prescription opioid pain medicines, due to our nation’s ongoing crisis of misuse, abuse, addiction and overdose.

PHILADELPHIA — The benefits of prescribing opioids to patients with migraines usually do not outweigh the risk, a past president of the American Headache Society told Healio Primary Care during the organization’s annual scientific meeting.

A lawsuit filed against London-based Reckitt Benckiser Group plc was recently settled for $1.4 billion, the largest settlement to date against an opioid manufacturer, according to a press release from the Department of Justice.

PHILADELPHIA — Opioid use continues to be “major issue” in adults with migraine, despite practices discouraging patients from using them, according to study results presented at the American Headache Society Annual Scientific Meeting.